Efficacy of tacrolimus 0.1% ointment in cutaneous lupus erythematosus: A multicenter, randomized, double-blind, vehicle-controlled trial
- 31 July 2011
- journal article
- research article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 65 (1), 54-64.e2
- https://doi.org/10.1016/j.jaad.2010.03.037
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Pimecrolimus 1% cream versus betamethasone 17-valerate 0.1% cream in the treatment of facial discoid lupus erythematosus: a double-blind, randomized pilot studyClinical and Experimental Dermatology, 2009
- A 4-year follow-up study of atopic dermatitis therapy with 0·1% tacrolimus ointment in children and adult patientsBritish Journal of Dermatology, 2008
- The US FDA ‘Black Box’ Warning for Topical Calcineurin InhibitorsDrug Safety, 2008
- Potential New Indications of Topical Calcineurin InhibitorsDermatology, 2007
- An Update on the Safety and Tolerability of Pimecrolimus Cream 1%: Evidence from Clinical Trials and Post-Marketing SurveillanceDermatology, 2007
- Tacrolimus vs. clobetasol propionate in the treatment of facial cutaneous lupus erythematosus: a randomized, double-blind, bilateral comparison studyBritish Journal of Dermatology, 2007
- Successful treatment with topical tacrolimus in four cases of discoid lupus erythematosusThe Journal of Dermatology, 2006
- Efficacy of topical tacrolimus in the treatment of various cutaneous manifestations of lupus erythematosusInternational Journal of Dermatology, 2005
- Pimecrolimus 1% cream for cutaneous lupus erythematosusJournal of the American Academy of Dermatology, 2004
- 0.1% Tacrolimus ointment in a patient with subacute cutaneous lupus erythematosusJournal of Dermatological Treatment, 2004